WORLD JOURNAL OF UROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2023-05-25 ms7000000194748269 来自北京

Reviews Completed会持续多久到下一步呐

39 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2023-07-06 ms9000000228172903 来自甘肃省

最近投稿发现这个期刊好慢，发帖跟踪下状态
6.19 New Submission
6.22 Editor Assigned

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2022-12-02 粥粥恒来自山东省

有人知道Reviews Completed一个月了，也没变化，是啥意思

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2022-08-21 m1867679976

偏重的研究方向：泌尿外科;肿瘤
经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2023-03-06 ms7000000194748269 来自北京

Under review 是外审吗

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2022-11-26 庸医小郝来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：太慢了，撤稿了

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2020-11-24 hellofish

有人投这个杂志吗？一个多星期了还是New Submission。

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

通讯作者最多有多少个？同第一作者最多有多少个？

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2020-03-04 wangyb1980

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。

165 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138982, encodeId=d5382138982d1, content=Reviews Completed会持续多久到下一步呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Thu May 25 13:54:36 CST 2023, time=2023-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146579, encodeId=8e5421465e989, content=最近投稿发现这个期刊好慢，发帖跟踪下状态 6.19 New Submission 6.22 Editor Assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Thu Jul 06 09:08:18 CST 2023, time=2023-07-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2103857, encodeId=79b0210385e75, content=有人知道Reviews Completed一个月了，也没变化，是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211110/08d15153131f4333aa480bcbd0c185fb/410cb8b679a84e67b1fa64179c45b467.jpg, createdBy=59cc5572126, createdName=粥粥恒, createdTime=Fri Dec 02 09:31:12 CST 2022, time=2022-12-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240059, encodeId=2594124005921, content=偏重的研究方向：泌尿外科;肿瘤 经验分享：请问一下最近投稿的人，new submit都已经五天了，之前没那么慢啊，有一样经历的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Sun Aug 21 07:18:10 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117936, encodeId=e0f7211e9360b, content=Under review 是外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b55717157, createdName=ms7000000194748269, createdTime=Mon Mar 06 14:34:10 CST 2023, time=2023-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102682, encodeId=f344210268274, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：太慢了，撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Sat Nov 26 00:00:06 CST 2022, time=2022-11-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=901819, encodeId=441690181944, content=有人投这个杂志吗？一个多星期了还是New Submission。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Tue Nov 24 16:54:37 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098386, encodeId=136010983863e, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585908, encodeId=26ce5859084c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投过三篇，中两篇，临床回顾研究，比较容易。只要送了外审，基本不会拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a4614950, createdName=wangyb1980, createdTime=Wed Mar 04 22:24:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195060, encodeId=eb5e119506023, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了两次都是被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e46451945, createdName=ms8000000488319610, createdTime=Sat Feb 19 12:28:08 CST 2022, time=2022-02-19, status=1, ipAttribution=)]

2022-02-19 ms8000000488319610

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投了两次都是被拒

62 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务